These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 26958067

  • 21. Kawasaki disease in Sicily: clinical description and markers of disease severity.
    Maggio MC, Corsello G, Prinzi E, Cimaz R.
    Ital J Pediatr; 2016 Nov 02; 42(1):92. PubMed ID: 27806720
    [Abstract] [Full Text] [Related]

  • 22. A Comprehensive Assessment of the Value of Laboratory Indices in Diagnosing Kawasaki Disease.
    Ye Q, Shao WX, Shang SQ, Zhang T, Hu J, Zhang CC.
    Arthritis Rheumatol; 2015 Jul 02; 67(7):1943-50. PubMed ID: 25778686
    [Abstract] [Full Text] [Related]

  • 23. Association between Alanine Aminotransferase/Aspartate Aminotransferase Ratio (AST/ALT Ratio) and Coronary Artery Injury in Children with Kawasaki Disease.
    Wang J, Li J, Ren Y, Shi H, Rong X, Zhang X, Shao Y, Wu R, Chu M, Qiu H.
    Cardiol Res Pract; 2020 Jul 02; 2020():8743548. PubMed ID: 32274211
    [Abstract] [Full Text] [Related]

  • 24. The factors affecting the disease course in Kawasaki disease.
    Arslanoglu Aydin E, Ertugrul I, Bilginer Y, Batu ED, Sonmez HE, Demir S, Arici ZS, Sag E, Alehan D, Ozen S.
    Rheumatol Int; 2019 Aug 02; 39(8):1343-1349. PubMed ID: 31139951
    [Abstract] [Full Text] [Related]

  • 25. Establishment and Validation of a Multivariate Predictive Scoring Model for Intravenous Immunoglobulin-Resistant Kawasaki Disease: A Study of Children From Two Centers in China.
    Li C, Wu S, Shi Y, Liao Y, Sun Y, Yan H, Zhang Q, Fu J, Zhou D, Zhang Y, Jin H, Du J.
    Front Cardiovasc Med; 2022 Aug 02; 9():883067. PubMed ID: 35571210
    [Abstract] [Full Text] [Related]

  • 26. Predictive tool for intravenous immunoglobulin resistance of Kawasaki disease in Beijing.
    Yang S, Song R, Zhang J, Li X, Li C.
    Arch Dis Child; 2019 Mar 02; 104(3):262-267. PubMed ID: 30026252
    [Abstract] [Full Text] [Related]

  • 27. Inflammatory cytokines as predictors of resistance to intravenous immunoglobulin therapy in Kawasaki disease patients.
    Sato S, Kawashima H, Kashiwagi Y, Hoshika A.
    Int J Rheum Dis; 2013 Apr 02; 16(2):168-72. PubMed ID: 23773640
    [Abstract] [Full Text] [Related]

  • 28. Prediction of nonresponsiveness to medium-dose intravenous immunoglobulin (1 g/kg) treatment: an effective and safe schedule of acute treatment for Kawasaki disease.
    Moon KP, Kim BJ, Lee KJ, Oh JH, Han JW, Lee KY, Lee SJ.
    Korean J Pediatr; 2016 Apr 02; 59(4):178-82. PubMed ID: 27186228
    [Abstract] [Full Text] [Related]

  • 29. Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease.
    Chen X, Gao L, Zhen Z, Wang Y, Na J, Yu W, Chu X, Yuan Y, Qian S.
    J Inflamm Res; 2022 Apr 02; 15():2877-2889. PubMed ID: 35571506
    [Abstract] [Full Text] [Related]

  • 30. Vital Signs as Predictor Factors of Intravenous Immunoglobulin Resistance in Patients With Kawasaki Disease.
    Gámez-González LB, Hamada H, Cisneros Castolo M, Honda T, Yasukawa K, Takanashi JI.
    Clin Pediatr (Phila); 2018 Sep 02; 57(10):1148-1153. PubMed ID: 29486579
    [Abstract] [Full Text] [Related]

  • 31. [Expression of sICAM-1 in children with intravenous immunoglobulin-resistant Kawasaki disease].
    Liu F, Ding Y, Yin W.
    Zhongguo Dang Dai Er Ke Za Zhi; 2013 Dec 02; 15(12):1109-12. PubMed ID: 24342209
    [Abstract] [Full Text] [Related]

  • 32. Delayed intravenous immunoglobulin treatment increased the risk of coronary artery lesions in children with Kawasaki disease at different status.
    Qiu H, He Y, Rong X, Ren Y, Pan L, Chu M, Wu R, Shi H.
    Postgrad Med; 2018 May 02; 130(4):442-447. PubMed ID: 29745742
    [Abstract] [Full Text] [Related]

  • 33. Utility of Soluble CD163 in the Clinical Management of Patients With Kawasaki Disease.
    Azuma Y, Suzuki Y, Okada S, Matsuguma C, Wakiguchi H, Ohnishi Y, Furuta T, Miyake A, Yasudo H, Ichihara K, Ohga S, Hasegawa S.
    Front Pediatr; 2020 May 02; 8():148. PubMed ID: 32318530
    [Abstract] [Full Text] [Related]

  • 34. Prediction of non-responsiveness to standard high-dose gamma-globulin therapy in patients with acute Kawasaki disease before starting initial treatment.
    Sano T, Kurotobi S, Matsuzaki K, Yamamoto T, Maki I, Miki K, Kogaki S, Hara J.
    Eur J Pediatr; 2007 Feb 02; 166(2):131-7. PubMed ID: 16896641
    [Abstract] [Full Text] [Related]

  • 35. N-terminal pro-brain natriuretic peptide and risk of coronary artery lesions and resistance to intravenous immunoglobulin in Kawasaki disease.
    Yoshimura K, Kimata T, Mine K, Uchiyama T, Tsuji S, Kaneko K.
    J Pediatr; 2013 Jun 02; 162(6):1205-9. PubMed ID: 23290510
    [Abstract] [Full Text] [Related]

  • 36. A comparison of serum IL6 and CRP levels with respect to coronary changes and treatment response in Kawasaki disease patients: a prospective study.
    Nandi A, Pal P, Basu S.
    Rheumatol Int; 2019 Oct 02; 39(10):1797-1801. PubMed ID: 31302740
    [Abstract] [Full Text] [Related]

  • 37. Prediction of resistance to intravenous immunoglobulin treatment in patients with Kawasaki disease.
    Egami K, Muta H, Ishii M, Suda K, Sugahara Y, Iemura M, Matsuishi T.
    J Pediatr; 2006 Aug 02; 149(2):237-40. PubMed ID: 16887442
    [Abstract] [Full Text] [Related]

  • 38. Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
    Chan H, Chi H, You H, Wang M, Zhang G, Yang H, Li Q.
    BMC Pediatr; 2019 May 17; 19(1):158. PubMed ID: 31101091
    [Abstract] [Full Text] [Related]

  • 39. Efficacy of infliximab in the treatment of Kawasaki disease: A systematic review and meta-analysis.
    Lu Z, Wang F, Lv H.
    Exp Ther Med; 2021 Jan 17; 21(1):15. PubMed ID: 33235624
    [Abstract] [Full Text] [Related]

  • 40. Efficacy of intravenous immunoglobulin combined with prednisolone following resistance to initial intravenous immunoglobulin treatment of acute Kawasaki disease.
    Kobayashi T, Kobayashi T, Morikawa A, Ikeda K, Seki M, Shimoyama S, Ishii Y, Suzuki T, Nakajima K, Sakamoto N, Arakawa H.
    J Pediatr; 2013 Aug 17; 163(2):521-6. PubMed ID: 23485027
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.